Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2025)

Historic Inventory Average for Iovance Biotherapeutics (IOVA) over the last 3 years, with Q3 2025 value amounting to $50.8 million.

  • Iovance Biotherapeutics' Inventory Average changed N/A to $50.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 million, marking a year-over-year change of. This contributed to the annual value of $30.9 million for FY2024, which is N/A changed from last year.
  • Per Iovance Biotherapeutics' latest filing, its Inventory Average stood at $50.8 million for Q3 2025.
  • In the past 5 years, Iovance Biotherapeutics' Inventory Average registered a high of $58.5 million during Q1 2025, and its lowest value of $9.5 million during Q3 2023.
  • In the last 3 years, Iovance Biotherapeutics' Inventory Average had a median value of $32.4 million in 2024 and averaged $33.4 million.
  • The largest annual percentage gain for Iovance Biotherapeutics' Inventory Average in the last 5 years was 31825.36% (2025), contrasted with its biggest fall of 31825.36% (2025).
  • Over the past 3 years, Iovance Biotherapeutics' Inventory Average (Quarter) stood at $9.8 million in 2023, then soared by 43.04% to $14.0 million in 2024, then surged by 262.8% to $50.8 million in 2025.
  • Its last three reported values are $50.8 million in Q3 2025, $57.7 million for Q2 2025, and $58.5 million during Q1 2025.